XML 39 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Statement of Cash Flows (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Nov. 30, 2011
Nov. 30, 2010
Cash flows from operating activities:    
Net income $ 14,783 $ 5,624
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 7,936 5,899
Bad debt expense 1,323 447
Equity in income of equity investees (3,255) (2,348)
Distribution of income from equity investees 1,288 694
Deferred income tax expense 2,257 2
Non-cash compensation adjustment 121 519
Non-cash stock based compensation expense 436 1,284
Loss on sale of property, plant and equipment 16 14
Impairment loss on marketable securities 1,225 182
Changes in operating assets and liabilities (net of assets and liabilities acquired):    
Accounts receivable (29,850) (1,522)
Inventory (5,203) (31,783)
Receivables from vendors 4,159 3,128
Prepaid expenses and other (630) 4,987
Investment securities-trading 395 (627)
Accounts payable, accrued expenses, accrued sales incentives and other current liabilities 29,293 6,174
Income taxes payable 3,444 2,323
Net cash provided by (used in) operating activities 27,738 (5,003)
Cash flows from investing activities:    
Purchases of property, plant and equipment (2,155) (2,506)
Purchase of short-term investments 0 (27,023)
Sale of short-term investments 0 3,032
Purchase of long term investments 0 (200)
Proceeds from sale of long-term investments 0 4,368
Repayment of notes receivable 175 139
Purchase of acquired business (167,271) (172)
Net cash used in investing activities (169,251) (22,362)
Cash flows from financing activities:    
Repayment of short-term debt (660) (3,593)
Principal payments on capital lease obligation (66) (158)
Repayment of bank obligations (27,225) (1,401)
Borrowings on bank obligations 89,702 558
Proceeds from exercise of stock options 0 499
Net cash provided by (used in) financing activities 61,751 (4,095)
Effect of exchange rate changes on cash (32) (228)
Net decrease in cash and cash equivalents (79,794) (31,688)
Cash and cash equivalents at beginning of period 98,630 69,511
Cash and cash equivalents at end of period $ 18,836 $ 37,823